Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up | MicrobiomeTrials← Back to trialsNCT07209852
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-12-19Est. Completion: 2029-08-31
Enrollment target: 140 participants Locations- St. Jan-Hospital, Bruges, Belgium
- Clinique Saint-Pierre Ottignies-Hospital, Brussels, Belgium
- CHRU de Lille, Lille, France
- Hospital Europeen Georges-Pompidou (HEGP), Paris, France
- Marienhospital-Hospital, Osnabrück, Lower Saxony, Germany
- Saarland University Hospital, Homburg, Saarland, Germany
- Azienda Ospedaliero-Universitaria di Ferrara-Hospital, Ferrara, Emilia-Romagna, Italy
- Azienda Ospedaliera Ospedale Niguarda Ca Granda, Milan, Italy
- AOU Maggiore, Novara, Italy
- Virgen de las Nieves University Hospital, Granada, Spain
- Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain
- Inselspital Bern, Bern, Switzerland
- East Surrey Hospital, Redhill, Surrey, United Kingdom
Other microbiome trials you might be interested in
Bradycardia
The purpose of this study is to collect and compare the heart's electrical activity data measured by the novel Conductio…
Madurai, IndiaEst. completion Jul 30, 2027
Benign Prostatic HyperplasiaTransurethral Resection of the Prostate (TURP)
This prospective randomized clinical trial aims to compare the effects of spinal and general anesthesia on perioperative…
Istanbul, Turkey (Türkiye)Completed Mar 31, 2025
Jens Goetzke, Dipl.-Ing. (FH)
The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurat…
Rochester, United StatesEst. completion Dec 2027